CB
Chubb Limited
CB offers stronger valuation, but that advantage does not outweigh its weaker overall profile.
JPM
JPMorgan Chase & Co.
JPM has a slight edge over CB overall, supported by stronger modeled upside and stronger fundamentals.
CB Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Strong | |
| N/A | |
| N/A |
CB's profitability is currently strong, and its revenue is stable. Free cash flow and net leverage aren't meaningful measures for financial services companies like CB.
JPM Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| N/A | |
| N/A |
JPM's revenue and profitability are currently healthy. Free cash flow and net leverage aren't meaningful measures for financial services companies like JPM.
CB PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 11x | $317 | -15% |
| Fair | 13x | $363 | -2.3% |
| Current | 13x | $372 | — |
| Forward | 13x | $372 | — |
| Expensive | 16x | $457 | +23% |
Historical ranges are pointers, not guarantees.
CB has the edge over JPM in the historical PE scenario, which offers more potential upside but is not a forecast.
JPM PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 9.7x | $231 | -33% |
| Fair | 12x | $287 | -16% |
| Current | 14x | $343 | — |
| Forward | 14x | $343 | — |
| Expensive | 15x | $361 | +5.2% |
Historical ranges are pointers, not guarantees.
JPM's PE is in its expensive range at 14.4x. If earnings grow as analysts expect, today's price would be 13.7x next year's earnings.
CB Forward outlook
| Metric | Outlook |
|---|---|
| Stable | |
| Growth | |
| Stable | |
| Improving | |
| Moderate | |
| Moderate |
Analysts expect CB's earnings to grow and its profitability to improve, with its revenue holding steady.
JPM Forward outlook
| Metric | Outlook |
|---|---|
| Stable | |
| Growth | |
| Growth | |
| Improving | |
| Limited | |
| Moderate |
JPM has the edge over CB on the outlook, with more favorable revenue expectations.
CB Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $28.98 | +1.6% |
| Q3 2026 | $28.53 | +19% |
| Q2 2026 | $28.22 | +25% |
| Q1 2026 | $28.27 | +36% |
| Q4 2025 | $25.68 | +13% |
| Q3 2025 | $23.94 | -1.8% |
| Q2 2025 | $22.65 | -4.2% |
| Q1 2025 | $20.76 | -7.7% |
| Q4 2024 | $22.70 | +4.1% |
CB earned $28.53 per share over the past year, up 19% from the year before.
JPM Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $24.99 | +4.8% |
| Q3 2026 | $23.85 | +18% |
| Q2 2026 | $23.35 | +20% |
| Q1 2026 | $20.89 | +2.5% |
| Q4 2025 | $20.02 | +1.4% |
| Q3 2025 | $20.20 | +12% |
| Q2 2025 | $19.50 | +8.7% |
| Q1 2025 | $20.38 | +23% |
| Q4 2024 | $19.75 | +22% |
JPM has the edge over CB on earnings, with more consistent year-over-year improvement.
CB Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $16.2B | +0.3% |
| Q2 2026 | $15.8B | +6.6% |
| Q1 2026 | $14.8B | +11% |
| Q4 2025 | $15.1B | +6.3% |
| Q3 2025 | $16.1B | +8.7% |
| Q2 2025 | $14.8B | +7.2% |
| Q1 2025 | $13.4B | +3.6% |
| Q4 2024 | $14.2B | +9.1% |
CB's revenue has grown year over year for 18 quarters in a row: $16.2B last quarter, about level with the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 21% | -3.1 points |
| Q2 2026 | 23% | -2.1 points |
| Q1 2026 | 20% | +7.8 points |
| Q4 2025 | 25% | +3 points |
| Q3 2025 | 24% | +3.9 points |
| Q2 2025 | 25% | +5.5 points |
| Q1 2025 | 12% | -8 points |
| Q4 2024 | 22% | +1.9 points |
CB's operating margin was 21% last quarter, down 3.1 points from the same quarter a year ago.
JPM Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $50.2B | +8.1% |
| Q2 2026 | $57.3B | +28% |
| Q1 2026 | $49.8B | +10% |
| Q4 2025 | $45.8B | +7.1% |
| Q3 2025 | $46.4B | +8.8% |
| Q2 2025 | $44.9B | -11% |
| Q1 2025 | $45.3B | +8.1% |
| Q4 2024 | $42.8B | +11% |
JPM's revenue has grown year over year for five quarters in a row: $50.2B last quarter, up 8.1% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 40% | -0.2 points |
| Q2 2026 | 48% | +7.3 points |
| Q1 2026 | 41% | +0.5 points |
| Q4 2025 | 37% | -3.2 points |
| Q3 2025 | 40% | +0.6 points |
| Q2 2025 | 41% | -6 points |
| Q1 2025 | 41% | -0.6 points |
| Q4 2024 | 41% | +11 points |
JPM has the edge over CB on profitability, with a higher operating margin.
CB Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $6.1B | +67% |
| Q2 2026 | $3.7B | +5% |
| Q1 2026 | $3.9B | +152% |
| Q4 2025 | $4.1B | -11% |
| Q3 2025 | $3.6B | -16% |
| Q2 2025 | $3.6B | -13% |
| Q1 2025 | $1.6B | -51% |
| Q4 2024 | $4.6B | +43% |
CB has the edge over JPM on cash generation, producing positive trailing cash flow while its opponent burns cash.
JPM Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $33.2B | +$78.4B |
| Q2 2026 | -$25.3B | -186% |
| Q1 2026 | -$211.8B | +$40.1B |
| Q4 2025 | $119.7B | -19% |
| Q3 2025 | -$45.2B | +$28.9B |
| Q2 2025 | $29.5B | -23% |
| Q1 2025 | -$251.8B | -$97.7B |
| Q4 2024 | $147.8B | +145% |
JPM's free cash flow was −$84.2B over the past year, against −$120B the year before. Free cash flow isn't a meaningful measure for financial services companies like JPM.
CB Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.5% | -1.9M shares |
| 1 year | -2.9% | -11.5M shares |
| 3 years | -5.6% | -23.2M shares |
| 5 years | -11% | -49.1M shares |
| Available history | -15% | -69.5M shares |
CB has 389M diluted shares, down 2.9% from a year ago, with $4.4B in buybacks over the past year.
| Quarter | Spent |
|---|---|
| Q3 2026 | $1B |
| Q2 2026 | $1.1B |
| Q1 2026 | $1.2B |
| Q4 2025 | $1.2B |
| Q3 2025 | $1.1B |
| Q2 2025 | $746M |
| Q1 2025 | $691M |
| Q4 2024 | $450M |
CB spent $4.4B buying back its own shares over the past year, up 50% from the year before.
JPM Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.4% | -11.2M shares |
| 1 year | -3.1% | -84.6M shares |
| 3 years | -8.5% | -249M shares |
| 5 years | -11% | -322M shares |
| Available history | -17% | -547M shares |
JPM has the edge over CB on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $1.1B |
| Q2 2026 | $6.8B |
| Q1 2026 | $8.3B |
| Q4 2025 | $8.3B |
| Q3 2025 | $8.3B |
| Q2 2025 | $7.5B |
| Q1 2025 | $7.5B |
| Q4 2024 | $4.3B |
JPM spent $24.5B buying back its own shares over the past year, down 11% from the year before.
CB Net Leverage
JPM Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.5x | Very low |
| Q2 2026 | 0.5x | Very low |
| Q1 2026 | 0.6x | Very low |
| Q4 2025 | 0.5x | Very low |
| Q3 2025 | 0.6x | Very low |
| Q2 2025 | 0.5x | Very low |
| Q1 2025 | 0.5x | Very low |
| Q4 2024 | 0.4x | Very low |
JPM's net debt is less than a year of its operating earnings (EBITDA). Net leverage isn't a meaningful measure for financial services companies like JPM.
CB Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 66.4 | Neutral |
| Stochastic | 78.5 | Neutral |
CB's weekly RSI is 66 (neutral) and its Stochastic is 78 (neutral).
JPM Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 54.8 | Neutral |
| Stochastic | 31.5 | Neutral |
JPM's weekly RSI is 55 (neutral) and its Stochastic is 31 (neutral).
CB PE vs Financial Services Sector
| Metric | CB | Sector median | Relative |
|---|---|---|---|
| PE | 13x | 13x | 0.1% above |
| PE % | 56 | 63 | 7 pts below |
CB has the edge over JPM on valuation relative to its sector.
JPM PE vs Financial Services Sector
| Metric | JPM | Sector median | Relative |
|---|---|---|---|
| PE | 14x | 13x | 10% above |
| PE % | 76 | 63 | 13 pts above |
JPM is trading at 14x earnings, a 10% premium to the Financial Services sector's median of 13x.
CB Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $352.7 | 5.4% above |
| 20 week MA | $349.4 | 6.4% above |
| 50 week MA | $332.3 | 12% above |
| 100 week MA | $306.4 | 21% above |
| 200 week MA | $271.1 | 37% above |
CB has the edge over JPM on trend strength, trading above more of its moving averages.
JPM Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $336.8 | 1.8% above |
| 20 week MA | $345.3 | 0.7% below |
| 50 week MA | $323.2 | 6.1% above |
| 100 week MA | $298.9 | 15% above |
| 200 week MA | $236.6 | 45% above |
JPM's trend is mixed: it's above four of its five weekly moving averages, and 45% above its 200-week average.
CB Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $155.8 | $150.8 | -3.2% |
| 2021 | $150.8 | $190.6 | +26% |
| 2022 | $190.6 | $219.7 | +15% |
| 2023 | $219.7 | $226.0 | +2.9% |
| 2024 | $226.0 | $277.7 | +23% |
| 2025 | $277.7 | $313.5 | +13% |
| 2026 YTD | $313.5 | $371.8 | +19% |
CB has the edge over JPM on returns for 2026, with the stronger performance.
JPM Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $139.1 | $124.5 | -11% |
| 2021 | $124.5 | $157.3 | +26% |
| 2022 | $157.3 | $131.3 | -17% |
| 2023 | $131.3 | $170.1 | +30% |
| 2024 | $170.1 | $241.2 | +42% |
| 2025 | $241.2 | $327.9 | +36% |
| 2026 YTD | $327.9 | $342.8 | +4.5% |
JPM has finished higher in four of the last six years. It's up 4.5% so far in 2026.